Țară: Malaezia
Limbă: engleză
Sursă: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
DROSPIRENONE; ETHINYLESTRADIOL
EURODRUG LABORATORIES (M) SDN. BHD.
DROSPIRENONE; ETHINYLESTRADIOL
21tablet Tablets
LABORATORIO LEON FARMA, S.A.
Consumer Medication Information Leaflet (RiMUP) _______________________________________________________________________________________ 1 LIZELLE 0.02MG/3MG FILM-COATED TABLETS _Ethinylestradiol 0.02mg + Drospirenone 3mg_ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about LIZELLE 0.02mg/3mg film-coated tablets. Read all of leaflet carefully before you start taking this medicine. Keep this leaflet, you may need to read it again. If you have any further question, ask your doctor or pharmacist. This medicine has been prescribed for you, do not pass it on to others. It may harm them. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell; your doctor or pharmacist. WHAT IS IN THIS LEAFLET: 1. WHAT LIZELLE IS USED FOR 2. HOW LIZELLE WORKS 3. BEFORE YOU TAKE LIZELLE 4. HOW TO TAKE LIZELLE 5. WHILE YOU ARE USING LIZELLE 6. SIDE EFFECTS 7. AFTER USING LIZELLE 8. PRODUCT DESCRIPTION WHAT LIZELLE 0.02MG/3MG FILM-COATED TABLETS IS USED FOR LIZELLE is a contraceptive and is used to prevent pregnancy. HOW LIZELLE 0.02MG/3MG FILM- COATED TABLETS WORKS The contraceptive effect of LIZELLE 0.02mg/3mg film-coated tablet is based on the interaction of various factors, the most important of which are seen as the inhibition of ovulation and the changes in the endometrium. LIZELLE 0.02mg/3mg film-coated tablet is a combined oral contraceptive with ethinylestradiol and the progestogen drospirenone. BEFORE YOU TAKE LIZELLE 0.02MG/3MG FILM-COATED TABLETS _WHEN YOU MUST NOT TAKE IT _ • if you have (or have had in the past) blood clots (thrombosis) in a blood vessel of the leg, lungs (embolism) or other organs • if you have (or have had in the past) a heart attack or a stroke • if you have (or have had in the past) any illness which could lead to a heart attack (for example, angina pectoris which causes serious pain in the chest) or a stroke (for example a temporary or minor stroke without residual effects). • if you have any illness which could increa Citiți documentul complet
Pharma Code Read Directions Pharma Code Read Directions FRONT SIDE / ANVERSO 222 X 510 1 MM P031 100% Dimensions: Scale: Material type: LEAFLET Drawing #: Date: Version: B XXXXX 08.07.22 - PR DREE LIZELLE 3-0,02 1X21 EXELTIS MY Laetus #: Folded: YES NO Substitutes mat. #: Material #/ Product : _LICONSA_ _LEON FARMA_ X _Launch:_ _Internal change:_ _Customer change:_ X Pantones: 170 X 37 MM die cut black 0000 Signature: Date: With the signed proof of this file you commit to have had reviewed and agreed with the following points as part of your review: - Keyline used. - Free varnish areas. - Colors. - Text. - Prefixes order for variable info (If the order is changed you commint to clearly comunicate this change to Chemo's artworks department, otherwise Chemo will not be responsible). - Any other info included in the file. DRAWED BY: APPROVED BY CUSTOMER (Regulatory Affair or Quality Assurance) EXAMPLE / EJEMPLO Pharma Code Read Directions xxxxx LIZELLE 0.02MG/3MG FILM-COATED TABLET QUALITATIVE AND QUANTITATIVE COMPOSITION 21 PINK/PEACH FILM-COATED TABLETS: Each film-coated tablet contains 0.02 mg of ethinylestradiol and 3 mg of drospirenone Excipient: Lactose monohydrate 44 mg PHARMACEUTICAL FORM Round, pink/peach film coated tablet. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS Oral contraception. POSOLOGY AND METHOD OF ADMINISTRATION For oral administration The tablets must be taken every day at about the same time, if necessary with a little liquid in the order shown on blister pack. LIZELLE 0.02MG/3MG FILM-COATED TABLET: One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after 7-day tablet-free interval, during which time withdrawal bleed occurs. This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started. • No preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman’s natural cycle (i.e. the first day of her menstrual bleeding). • Changing from a combined hormonal contra Citiți documentul complet